Providence / check coverage
A plain-language care & cost guide
Check what your plan pays for.
Start with the name on your insurance card and the exact medicine. Ask about the reason for care as well as the price.
Ask the plan to connect these
- Your health plan
- Medicine + reason for care
- Payment approval
- Your part of the bill
Rhode Island Medicaid’s announced change
Ask about the named medicine
Give the care service and Medicaid plan the full name. Ask how the change affects the prescription being discussed.
Rhode Island’s Medicaid memo, checked September 30, 2026, announces a change beginning October 1, 2026.
Medicaid will stop paying for these medicines when they are prescribed solely for weight loss:
- Semaglutide (Wegovy)
- Tirzepatide (Zepbound)
- Liraglutide (Saxenda)
- Orforglipron (Foundayo)
This memo concerns Medicaid, so it does not settle what a private plan pays.
Rhode Island: read the coverage memoMedicare: the reason for care matters
Name the reason on the prescription
Call the doctor or other health professional who orders your medicine. Then call the number on your Medicare drug-plan card. Ask whether your usual insurance or the temporary program below could pay, and what records are needed.
Under rules checked September 2026, Medicare’s usual prescription insurance, called Part D, does not pay for medicines used only for weight loss.
Medicare’s rules allow plans to consider other uses, such as treating type 2 diabetes or lowering heart risk in certain patients, as of September 2026.
Type 2 diabetes is a disease that causes high blood sugar.
Ask your drug plan whether the exact medicine is covered for the condition named by your doctor. An allowed use does not promise payment.
CMS: regular drug coverage rulesA temporary Medicare route has its own limits
Ask about the temporary program
Ask the doctor or other health professional who orders your medicine to check your health history against the rules below. Ask your Medicare drug plan to confirm whether your type of plan qualifies.
CMS is the government agency that runs Medicare.
As of September 2026, CMS lists a temporary weight-loss medicine program with a $50 monthly payment for eligible Medicare drug-plan members.
Your body makes GLP-1, a signal that affects blood sugar and hunger; GLP-1 drugs copy this signal.
This program is called the Medicare GLP-1 Bridge.
The program’s start date is July 1, 2026; its end date is December 31, 2027.
In 2026, a separate program service handles payment approval and pays pharmacies, instead of your usual Part D insurance.
Ask the pharmacy to confirm the program’s approval and the amount you owe before collecting the medicine.
You need a prescription and payment approval; the health, age and plan rules below were checked September 2026.
CMS: program detailsCMS: who can qualifyQuestions for a workplace or private plan
Get a clear answer from any plan
Is this exact medicine on the covered-drug list? Does the plan cover it for my reason for care?
Ask what approval means
Does the plan need a request before it pays? Who sends it? What will I pay after approval?
Ask about a refusal
What is the written reason? How can I ask the plan to review its decision? Ask the person who orders your medicine to explain the care options.
Prior authorization means asking a health plan to agree to payment before a prescription is filled.
Take questions to the visit